Is CVET undervalued or overvalued?
As of 2025-03-27, the Intrinsic Value of Covetrus Inc (CVET) is 6.63 USD. This CVET valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 20.99 USD, the upside of Covetrus Inc is -68.40%. This means that CVET is overvalued by 68.40%.
The range of the Intrinsic Value is 2.67 - 16.04 USD
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 2.67 - 16.04 | 6.63 | -68.4% |
| DCF (Growth 10y) | 5.62 - 22.36 | 10.64 | -49.3% |
| DCF (EBITDA 5y) | 8.46 - 15.48 | 10.37 | -50.6% |
| DCF (EBITDA 10y) | 9.29 - 20.62 | 13.04 | -37.9% |
| Fair Value | -0.46 - -0.46 | -0.46 | -102.21% |
| P/E | (1.53) - 6.45 | 0.45 | -97.9% |
| EV/EBITDA | (0.40) - 5.12 | 1.49 | -92.9% |
| EPV | 0.30 - 4.90 | 2.60 | -87.6% |
| DDM - Stable | (0.97) - (3.33) | (2.15) | -110.3% |
| DDM - Multi | 18.09 - 48.69 | 26.42 | 25.9% |
| Market Cap (mil) | 2,941.18 |
| Beta | 1.49 |
| Outstanding shares (mil) | 140.12 |
| Enterprise Value (mil) | 3,903.18 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.60% |
| Cost of Debt | 36.89% |
| WACC | 13.47% |